you are correct. The big fish got their fill and now looking for other tidbits to feast on.
Ask yourself this question: Why didn't Roche devour the whole enchilada? Was it because they wanted control of the data for themselves for the most part.
$30/share is my guess
IMO your thesis that the share price is less vulnerable after the Roche infusion fails to appreciate how the VC's see the future now. They are bailing because in the end a partnership is a sinking ship. $30 is my "Guess."
Another factor is the VC's winding down their positions. Which should say to investors that the sp upside is constrained.
The value of this company imo is the ip, not so much as their earnings potential. Roche wanted their data base for their use own before a competitor gobbled them. I don't believe we will see $50 again.
Increasing the dividend would be my choice. BB's signals that there is nothing better to put capital to work. Unless you're an AAPL with excess cash reserves to increase the pay back to shareholders, companies should use revenue to invest in their business.
My sense is the drop in SP is due to the $$ strength. The Street may feel that their export business is getting slammed and worrisome for next quarter's earnings.
Long & Strong
Third Rock, plus a slew of corporate types dumped an average of 78-percent of their holdings. At $50 pps not a bad deal. My suspicion is that we are in purgatory until Roche takes the entire enchilada.
Indeed. Now will Pharm discovery Co's be interested in using FMI service with a competitor joined at the hip?
Chill! For cripe sakes. If you don't have conviction on your investment then what the hell are you doing here.
The nomination to the BoD of Roche employees should allay all concerns.
Shire has applied to the FDA for dry eye treatment approval. This will be a major headwind for Eleven. The allergic conjunctivitis angle would still be a major plus.
Yep. That's how I see it. The other possibilities are that RHBBY decides to ok the 7.7M is not exactly what we wanted but give or take a another 1M we're ok. Or, they go hostile directly to the shareholders to buy the company out.